← back to search

Enyu Imai

Takara (Japan) · JP
Area of research
Nephrology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Chronic Kidney Disease and Diabetes, Renal Diseases and Glomerulopathies, Dialysis and Renal Disease Management, and Blood Pressure and Hypertension Studies.
h-index
72
citations
26,821
works
546
NIH funding
primary concept
Medicine
email

Recent publications

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
Nature Medicine 2025cited by 8position: middledoi
Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease
Annals of Internal Medicine 2024cited by 45position: middledoi
Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes
Journal of the American Society of Nephrology 2024cited by 20position: middledoi
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection
Kidney International 2024cited by 12position: middledoi
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.
2024cited by 10position: contributordoi
The comparison of four hypoxia-inducible factor prolyl hydroxylase inhibitors on drug potency and cost for treatment in patients with renal anemia.
2024cited by 2position: contributordoi
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine 2023cited by 144position: middledoi
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Journal of the American Society of Nephrology 2023cited by 23position: middledoi
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
Clinical Journal of the American Society of Nephrology 2023cited by 18position: middledoi
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
2022cited by 4position: contributordoi
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
Journal of the American Society of Nephrology 2021cited by 29position: middledoi
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
The Lancet Diabetes & Endocrinology 2019cited by 364position: middledoi
Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation
Journal of the American Society of Nephrology 2019cited by 113position: middledoi
A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression
Kidney and Blood Pressure Research 2019cited by 20position: contributordoi
Taming the chronic kidney disease epidemic: a global view of surveillance efforts
Kidney International 2014cited by 112position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tazeen H. Jafar · Duke-NUS Medical School7 papers (2019–2025)Hiddo J.L. Heerspink · Kidney Associates7 papers (2019–2025)Lesley A. Inker · Boston University7 papers (2019–2025)Tom Greene · University of Utah6 papers (2019–2024)Julia B. Lewis · Vanderbilt University Medical Center6 papers (2023–2025)Ronald D. Perrone · Tufts University5 papers (2019–2025)Philip Kam‐Tao Li · Hospital Authority5 papers (2023–2025)Giuseppe Remuzzi · Mario Negri Institute for Pharmacological Research5 papers (2014–2025)Hocine Tighiouart · Tufts University5 papers (2019–2025)Bart Maes · AZ Delta4 papers (2019–2025) · 4 papers (2019–2024)Thierry Hannedouche · Eurométropole de Strasbourg4 papers (2024–2025)Christoph Wanner · Smart Material (Germany)4 papers (2023–2025)Raymond O. Estacio · University of Colorado Boulder4 papers (2023–2024) · 3 papers (2023–2025)Gerald B. Appel · NewYork–Presbyterian Hospital3 papers (2023–2025)Jürgen Floege · University of Hong Kong3 papers (2023–2025)Willem Collier · University of Southern California3 papers (2023–2025)Brendon L. Neuen · Royal North Shore Hospital3 papers (2023–2025)Mark Woodward · University of Technology Sydney3 papers (2024–2024)